ICI-REFRACTORY

Clinical trials for ICI-REFRACTORY explained in plain language.

Never miss a new study

Get alerted when new ICI-REFRACTORY trials appear

Sign up with your email to follow new studies for ICI-REFRACTORY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for lung cancer patients when standard immunotherapy fails

Disease control Recruiting now

This study is testing whether an experimental drug called SAR445877 can help control advanced non-small cell lung cancer in patients whose cancer has continued to grow despite previous immunotherapy treatment. The trial will enroll about 29 adults who have exhausted other standar…

Matched conditions: ICI-REFRACTORY

Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Mar 27, 2026 12:38 UTC

ICI-REFRACTORY

Get alerted when new ICI-REFRACTORY trials appear

New hope for lung cancer patients when standard immunotherapy fails